Skip to main content
SpringerLink
Log in

Patiententypen und Lebensstil

Individualisierte HIV-Therapie ist angesagt

HIV — Individualized therapy is announced

  • FORTBILDUNG . ÜBERSICHT
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Die HIV-Therapie ist heute differenziert wie nie. Erst die individualisierte Therapie, angepasst an den Lebensstil des Patienten, sichert den Behandlungserfolg. Ein Überblick über Patiententypen und passende, moderne Therapiekonzepte.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Gulick RM. Choosing Initial Antiretroviral Therapy: Current Recommendations for Initial Therapy and Newer or Investigational Agents. Top Antivir Med. 2015;23(4): 128–31.

    PubMed  Google Scholar 

  2. Wolf T Fuß B, Khaykin P, Berger A, Knecht G, Gute P, Brodt HR, Goepel S, Bickel M, Stuermer M, Stephan C. Improved virological and immunological efficacy of resistance-guided switch in antiretroviral therapy: a Frankfurt HIV cohort analysis. Med Microbiol Immunol 2014;203:409–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Robert-Koch-Institut (Hg.). Epidemiologisches Bulletin 2015; 45:475-86.

  4. Robert-Koch-Institut (Hg.). Epidemiologisches Bulletin 2014; 26:219.

  5. Lucas SB, Curtis H, Johnson MA. National review of deaths among HIV-infected adults. Clin Med (Lond) 2008;8(3):250–2.

    Article  CAS  Google Scholar 

  6. European Centre for Disease Prevention and Control (ECDC)/WHO Regional Office for Europe. HIV/AIDS Surveillance in Europe 2012. Stockholm: ECDC, 2013. Link: http://www.eurosurveillance.org (letzter Zugriff Mai 2014).

  7. Gandhi M, Gandhi R. Single-Pill Combination Regimens for Treatment of HIV-1 Infection. N Engl J Med 2014;371:248–59.

    Article  PubMed  Google Scholar 

  8. Margolis DA, Boffito M. Long-acting antiviral agents for HIV treatment. Current opinion in HIV and AIDS. 2015;10:246–252.

    Article  CAS  PubMed  Google Scholar 

  9. Chauvin B, Drouot S, Barrail-Tran A, Taburet AM. Drug-drug interactions between HMG-CoA reductase inhibitors (statins) and antiviral protease inhibitors. Clin Pharmacokinet 2013;52(10):815–31.

    Article  CAS  PubMed  Google Scholar 

  10. Group ISS, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, Avihingsanon A, Cooper DA, Fatkenheuer G et al: Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med 2015, 373(9):795–807.

    Article  Google Scholar 

  11. Emery S, Neuhaus JA, Phillips AN, et al. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. J Infect Dis 2008; 197:1133–44.

    Article  PubMed  Google Scholar 

  12. EACS Guidelines (Version 7.02), Juni 2014. Online unter: www.eacsociety.org

Download references

Author information

Authors and Affiliations

  1. Schwerpunkt Infektiologie/HIVCENTER, Universitätsklinikum Frankfurt, Theodor-Stern-Kai 7, D-60590, Frankfurt, Deutschland

    Christoph Stephan

Authors
  1. Christoph Stephan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christoph Stephan.

Additional information

This article is part of a supplement not sponsored by the industry.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stephan, C. Individualisierte HIV-Therapie ist angesagt. MMW - Fortschritte der Medizin 158 (Suppl 2), 48–54 (2016). https://doi.org/10.1007/s15006-016-8328-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-016-8328-4

Keywords

Search

Navigation